Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individualized ATG Dosing in Unrelated Donor HSCT
NCT07648992Phase 4Recruiting
- Sponsor
- Daihong Liu
- Start
- Dec 2025
- Primary completion
- Dec 2029
- Countries
- 1
01
Overview
A Phase 4 trial of antithymocyte globulin rabbit in graft-versus-host disease (GVHD), cytomegalovirus infection (CMV), sponsored by Daihong Liu. Started Dec 2025; status: recruiting.
02
Drugs
antithymocyte globulin rabbit
03
Conditions
graft-versus-host disease (GVHD)cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT07648992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07648992.